ZLAB’s Vyvgart revenue has been impressive, rising from roughly $93.6 million in 2024. Read more about ZLAB stock here.

Largest safety data set on FcRn blocking demonstrates consistent, favorable safety profileof VYVGART and VYVGART HytrulogMG patients on VYVGART ...

House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for ...

The ambulatory infusion suite is operated by registered nurses who specialise in treating patients with complex conditions.

KORU Medical Systems (NASDAQ:KRMD – Get Free Report) and Sintx Technologies (NASDAQ:SINT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the ...

Argenx (ARGX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

That's also why we're advancing empasiprubart in CIDP despite the fact that we printed the highest response rate average 70%. There is a 30% of patients which have a medical need and were not ...

Appointments can be arranged by calling the location at 260.344.4646 or by referral from patients’ medical ... among others, chronic inflammatory demyelinating polyneuropathy (CIDP ...

In lieu of flowers, please consider a donation to the GBS/CIDP Foundation International or to Penn State St. Joseph Medical Center. Online condolences can be made at maestumpfuneralhome.com ...

Batoclimab is an anti-FcRn treatment being developed for a range of autoimmune diseases and active thyroid eye disease (TED).